New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
In addition to broadcast television, the series will benefit from targeted earned media placements, amplifying exposure through high-visibility press outlets and digital media channels. Complementing the broadcast and earned media strategy, The new series features continued broadcast television interviews, earned media placements, and a comprehensive outdoor advertising campaign.
新系列將繼續在廣播電視節目中接受採訪，獲得媒體報道，並開展全面的戶外廣告活動。
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / New to The Street, one of the leading U.S. business television platforms, is pleased to announce the renewal of its media partnership with Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), a late-stage biopharmaceutical company. The new series features continued broadcast television interviews, earned media placements, and a comprehensive outdoor advertising campaign.
紐約，紐約/ ACCESSWIRE/ 2024年10月14日/ 美國領先的商業電視平台之一New to The Street很高興宣佈與Acurx Pharmaceuticals, Inc. (納斯達克:ACXP)續簽合作伙伴關係。新系列將繼續在廣播電視節目中接受採訪，獲得媒體報道，並開展全面的戶外廣告活動。
As part of this extended partnership, Acurx Pharmaceuticals will be featured on New to The Street's national television broadcasts. The series will spotlight the company's latest developments, milestones, and its leadership in addressing critical bacterial infections through innovative antibiotics. The coverage will air across major networks, enhancing Acurx Pharmaceuticals' brand visibility and reputation within the biopharmaceutical sector.
作爲這一擴展合作的一部分，Acurx Pharmaceuticals將在New to The Street的全國電視廣播中亮相。該系列將重點介紹公司最新的發展、里程碑以及通過創新抗生素解決關鍵細菌感染方面的領導地位。報道將在主要網絡上播出，提高Acurx Pharmaceuticals在生物製藥領域的品牌知名度和聲譽。
In addition to broadcast television, the series will benefit from targeted earned media placements, amplifying exposure through high-visibility press outlets and digital media channels. Complementing the broadcast and earned media strategy, Acurx Pharmaceuticals will also receive support from New to The Street's outdoor advertising platforms, including iconic billboard placements in strategic locations such as Times Square and the Financial District.
除了廣播電視，該系列還將受益於有針對性的媒體報道，通過高曝光度的新聞媒體和數字媒體渠道擴大曝光。作爲對廣播和媒體策略的補充，Acurx Pharmaceuticals還將得到New to The Street戶外廣告平台的支持，包括在時代廣場和金融區等戰略位置的標誌性廣告牌。
"We are thrilled to continue our collaboration with Acurx Pharmaceuticals as they progress in their mission to combat difficult-to-treat bacterial infections," said Vince Caruso CEO of New to The Street. "Our multi-platform approach-combining national television, earned media, and outdoor campaigns-ensures their message reaches the right audience at scale."
"我們很高興與Acurx Pharmaceuticals繼續合作，他們在解決難治細菌感染的使命中取得進展，"New to The Street的CEO文斯·卡魯索說。"我們的多平台方法-結合全國電視、媒體報道和戶外廣告活動-確保他們的信息有效地傳達給合適的受衆。"
The media series is set to begin airing immediately, 2024, with outdoor and earned media elements running concurrently to maximize audience reach.
該媒體系列將立即開始播出，2024年，戶外和媒體要素將同時運行，以最大限度地擴大觀衆群體。
For more information about New to The Street and its upcoming programming, visit
有關New to The Street及其即將推出的節目的更多信息，請訪問
About New to The Street
New to The Street is a leading business television program, airing on major U.S. networks such as FOX Business and Bloomberg through sponsored programming. With over 15 years of experience, the platform delivers in-depth interviews with CEOs and executives from high-growth companies across various industries.
關於《新生活》
《New to The Street》是一檔領先的商業電視節目，在美國主要電視網絡如FOX Business和彭博社贊助播出。藉助15年的經驗，該平台展示了與高增長公司的CEO和高管進行的深入訪談，涵蓋各行各業。
Following the national broadcasts, New to The Street amplifies its reach by sharing interviews across its robust social media channels, including nearly 2 million YouTube subscribers and extensive audiences on X (formerly Twitter), LinkedIn, and Instagram. The platform's earned media campaigns consistently secure over 50 pickups weekly across top-tier networks like ABC, NBC, and CBS, providing further exposure on morning and evening business news segments.
在全國廣播之後，《New to The Street》通過在其強大的社交媒體渠道上分享訪談內容來擴大觸及範圍，包括擁有近200萬YouTube訂閱用戶和在X（前身爲Twitter）、LinkedIn和Instagram上擁有龐大觀衆群。該平台的賺取媒體活動每週在ABC、NBC和CBS等一流網絡上都有超過50次報道，進一步曝光於早間和晚間商業資訊節目。
Through its recent collaboration with AccreditedEvents.com, New to The Street offers clients the opportunity to connect with top-tier family offices, retail investors, and private equity firms at exclusive NYC non-deal roadshow events-positioning companies directly in front of key investors.
通過最近與AccreditedEvents.com的合作，《New to The Street》爲客戶提供了與一流家族辦公室、散戶投資者和私募股權公司建立聯繫的機會，在紐約市獨家非交易路演活動中，直接將企業置於關鍵投資者面前。
For more information, visit
要獲取更多信息，請訪問
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and drug-resistant Streptococcus pneumoniae (DRSP). To learn more about Acurx Pharmaceuticals and its product pipeline, please visit .
關於Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals是一家專注於開發新型小分子抗生素的晚期生物製藥公司。該公司的方法是開發具有革蘭氏陽性選擇性譜（GPSS）的抗生素候選藥物，能夠阻斷革蘭氏陽性特異性細菌酶DNA聚合酶IIIC（pol IIIC）的活性位點，抑制DNA複製，從而導致革蘭氏陽性細菌細胞死亡。其研發管線包括針對革蘭氏陽性細菌的抗生素產品候選藥物，包括腸炎梭菌、耐甲氧西林金黃色葡萄球菌（MRSA）、耐萬古黴素腸球菌（VRE）和耐藥鏈球菌（DRSP）。要了解更多關於Acurx Pharmaceuticals及其產品管線的信息，請訪問。
Contact Information
聯繫信息
Monica Brennan
Head of Operations
monica@newtothestreet.com
Monica Brennan
運營主管
monica@newtothestreet.com
Related Images
相關圖像
SOURCE: New to The Street
消息來源：New to The Street
譯文內容由第三人軟體翻譯。
